We are live on ! Find out more

89 hedge funds and large institutions have $32M invested in iBio in 2020 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 14

133% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 9

16% more funds holding

Funds holding: 7789 (+12)

0.01% more ownership

Funds ownership: 0.02%0.03% (+0.01%)

1% less capital invested

Capital invested by funds: $32.4M → $32M (-$414K)

35% less call options, than puts

Call options by funds: $614K | Put options by funds: $944K

Holders
89
Holders Change
+12
Holders Change %
+15.58%
% of All Funds
1.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
39
Reduced
14
Closed
9
Calls
$614K
Puts
$944K
Net Calls
-$330K
Net Calls Change
-$260K

IBIO Hedge Fund Activity: Q4 2020 in Review

89 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2020, worth a combined $32M — down 1.3% from $32.4M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IBIO positions and 9 closed out — a net gain of 12 holders — while 39 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $9.98M. The largest seller was Osaic Holdings, cutting an estimated $466K.

  • 89 institutional investors held iBio (IBIO) as of Q4 2020, up from 77 in Q3 2020.
  • Funds reported $32M of iBio stock for Q4 2020, down 1.3% quarter-over-quarter.
  • 21 funds opened new iBio positions in Q4 2020 and 9 closed out, a net change of +12 holders.
  • The largest iBio buyer in Q4 2020 was BlackRock, an estimated $9.98M added.
  • The largest iBio seller in Q4 2020 was Osaic Holdings, an estimated $466K sold.

Based on aggregated 13F filings for Q4 2020.